Patients receiving etanercept may develop antibodies that interfere with monoclonal antibody laboratory assays.
Russell
E
E
Medical College of Wisconsin, Milwaukee, USA.
Zeihen
M
M
Wergin
S
S
Litton
T
T
D000818:Animals; D000906:Antibodies / Q000009:adverse effects; D000911:Antibodies, Monoclonal; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003429:Cross Reactions / Q000276:immunology; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000737:chemistry / Q000276:immunology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000737:chemistry / Q000276:immunology / Q000627:therapeutic use*
D000906:Antibodies; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept